HCS Capital

Venture Capital Active Herzliya, Israel Est. 2019
Visit website ↗ LinkedIn
Last updated 2026-06-18
Portfolio
10
in our dataset
Rounds participated
11
Rounds led
3
Rounds' value
$58.0M
total disclosed, rounds participated
Stages
Seed, Pre-Seed, A Round, B Round

About

HCS is focused on rounds A and B, within a variety of segments in the High Tech and Life Sciences ecosystems, while having the flexibility to invest earlier, as well as “stay for the course” through the growth stage. HCS has substantial involvement in the strategy, business development and fundraising aspects of portfolio companies, relying on its experienced Israeli team, as well as the experience and global network of its investors.

Portfolio · 10

Octup
E-Commerce Operation Optimization
2 rounds $16.0M committed Latest: 2025-07
RedDress
Regenerative Wound Care Technology
1 round $26.0M committed Latest: 2023-05
CardiacSense
Medical Watch for Detecting and Monitoring Heart Arrhythmias
Led ★ 1 round Latest: 2023-02
General Robotics
Robotics Platforms for Defense and Homeland Security
Led ★ 1 round Latest: 2023-02
RenoVate Therapeutics
Regenerative Kidney Therapeutics
Led ★ 1 round Latest: 2022-03
Cognni
Zero-effort Information Intelligence
1 round Latest: 2021-10
SCADAfence
OT and IoT Cyber Security Platform for Critical Infrastructure and Enterprises
1 round $12.0M committed Latest: 2021-03
GistMD
Personalized Patient Education and Engagement Platform
1 round $1.7M committed Latest: 2021-01
Anachoic
Head-mounted Assistance System
1 round $2.3M committed Latest: 2020-02
Sanoculis
Minimally Invasive Surgical Device for Glaucoma Treatment
1 round Latest: 2019-09

Investment activity

2 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences5
Automotive & Mobility Technologies2
Cyber Security2
Aerospace, Defense & HLS1

Q&A

What is HCS Capital's primary investment focus by stage?
HCS Capital primarily focuses on Series A and Series B rounds, with flexibility for earlier-stage investments and continued support through growth stages.
Which sectors does HCS Capital prioritize for investments?
HCS Capital shows a strong concentration in Health Tech & Life Sciences, with 5 portfolio companies in this sector. They also invest in Automotive & Mobility Technologies, Cyber Security, and Aerospace, Defense & HLS.
Can you name some of HCS Capital's notable portfolio companies?
HCS Capital's portfolio includes companies like CardiacSense, which raised $24.43M in a Series A round, and RedDress, which secured $42.5M in a Series D round.
Has HCS Capital had any recent exits?
Yes, HCS Capital had two exits in 2023. SCADAfence was acquired by Honeywell in July 2023, and General Robotics was acquired by SIG SAUER in March 2023.
What is the typical check size for HCS Capital's investments?
HCS Capital's investment range is between $1.69M and $26M.
When was HCS Capital founded and where is it headquartered?
HCS Capital was founded in 2019 and is headquartered in Herzliya, Israel.
Who are the co-founders and co-managing directors of HCS Capital?
Ron Lubash and Meirav Shiri are the Co-founder & Co-Managing Directors of HCS Capital.
What is HCS Capital's approach to supporting its portfolio companies?
HCS Capital is substantially involved in the strategy, business development, and fundraising aspects of its portfolio companies, leveraging its experienced Israeli team and global network of investors.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)